These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25402815)

  • 1. Increased platelet count after treatment with venlafaxine or mirtazapine in depressed patients.
    Gronau W; Paslakis G; Lederbogen F; Weber-Hamann B; Gilles M; Schilling C; Deuschle M
    Pharmacopsychiatry; 2015 Jan; 48(1):37-9. PubMed ID: 25402815
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
    Scharnholz B; Weber-Hamann B; Lederbogen F; Schilling C; Gilles M; Onken V; Frankhauser P; Kopf D; Deuschle M
    Psychiatry Res; 2010 May; 177(1-2):109-13. PubMed ID: 20381159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
    Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
    Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.
    Lecei O; Lederbogen F; Gronau W; Scharnholz B; Terhardt J; Schilling C; Gilles M; Kopf D; Roth HJ; Weber-Hamann B; Deuschle M
    J Clin Psychopharmacol; 2012 Aug; 32(4):574-6. PubMed ID: 22760352
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
    Deuschle M; Gilles M; Scharnholz B; Lederbogen F; Lang UE; Hellweg R
    Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
    Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
    Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural correlates of treatment outcome in major depression.
    Lisiecka D; Meisenzahl E; Scheuerecker J; Schoepf V; Whitty P; Chaney A; Moeller HJ; Wiesmann M; Frodl T
    Int J Neuropsychopharmacol; 2011 May; 14(4):521-34. PubMed ID: 21205435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.
    Frodl T; Scheuerecker J; Schoepf V; Linn J; Koutsouleris N; Bokde AL; Hampel H; Möller HJ; Brückmann H; Wiesmann M; Meisenzahl E
    J Clin Psychiatry; 2011 Apr; 72(4):448-57. PubMed ID: 20868630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
    Ladeira RB; Cunha FT; Salgado JV; Teixeira AL; Nicolato R
    Braz J Psychiatry; 2008 Sep; 30(3):299-300. PubMed ID: 18833439
    [No Abstract]   [Full Text] [Related]  

  • 12. Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
    Paslakis G; Luppa P; Gilles M; Kopf D; Hamann-Weber B; Lederbogen F; Deuschle M
    J Psychiatr Res; 2010 Jun; 44(8):556-60. PubMed ID: 20022345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
    Liappas J; Paparrigopoulos T; Tzavellas E; Rabavilas A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):55-60. PubMed ID: 15610945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining antidepressant medications: a good idea?
    Rush AJ
    Am J Psychiatry; 2010 Mar; 167(3):241-3. PubMed ID: 20194484
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine.
    Weber-Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Kopf D; Lederbogen F; Deuschle M
    J Clin Psychopharmacol; 2008 Oct; 28(5):581-4. PubMed ID: 18794665
    [No Abstract]   [Full Text] [Related]  

  • 18. Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
    Schilling C; Gilles M; Blum WF; Daseking E; Colla M; Weber-Hamann B; Lederbogen F; Krumm B; Heuser I; Wudy SA; Kopf D; Deuschle M
    J Clin Psychopharmacol; 2013 Feb; 33(1):99-103. PubMed ID: 23277262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate variability during antidepressant treatment with venlafaxine and mirtazapine.
    Terhardt J; Lederbogen F; Feuerhack A; Hamann-Weber B; Gilles M; Schilling C; Lecei O; Deuschle M
    Clin Neuropharmacol; 2013; 36(6):198-202. PubMed ID: 24201230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D; Trivedi MH; Carmody T; Toups M; Zisook S; Lesser I; Myers A; Kurian KR; Morris D; Rush AJ
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.